CDC20 and cancer: Furthermore, use of the pharmacological agents APCIN or pro-TAME, which inhibit the binding of CDC20 to the APC (and thus APCCDC20 formation) resulted in increased apoptosis and death in multiple cancer cell lines, indicating that inhibition of the APC may be a useful anticancer approach [42–44].